Stock listing
864318 Stock Price, News, Filings & Events — Santen Pharmaceutical Co., Ltd.
Selected listing: 864318 · LS · EUR · DE
This page tracks Santen Pharmaceutical Co., Ltd.'s 864318:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 864318:LS. 864318:LS is the stock-level entry point for investors researching Santen Pharmaceutical Co., Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 864318:LS
- Asset type
- Stock
- Market cap
- $3.64B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Santen Pharmaceutical Co., Ltd. 864318:LS stock context
This page tracks Santen Pharmaceutical Co., Ltd.'s 864318:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 864318:LS. 864318:LS is the stock-level entry point for investors researching Santen Pharmaceutical Co., Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Santen Pharmaceutical Co., Ltd.
Santen Pharmaceutical : New Drug Application Filing Accepted for Review in China for STN1012700 (Atropine Sulfate Ophthalmic Solution 0.0...
September 14, 2026
Notice on the Disposal of Treasury Shares for the Post-delivery Type Performance-Linked Stock Remuneration Plan
September 3, 2026
Summary of Consolidated Financial Results for the Three Months Ended June 30, 2026 (IFRS)
August 6, 2026
Teijin Receives Approval for Additional Indications of XEOMIN® for Cervical Dystonia and Blepharospasm in Japan
June 19, 2026
Santen Pharmaceutical : China Signs Exclusive Distribution and Promotion Agreement for Five Marketed Glaucoma Eyedrops Products in the Ch...
April 16, 2026
Research Santen Pharmaceutical Co., Ltd.
Santen Pharmaceutical Co., Ltd. investor report
Review AI stock analysis and investor report context for 864318:LS.
Santen Pharmaceutical Co., Ltd. company profile
View the public company page for Santen Pharmaceutical Co., Ltd. on 6ix.
Santen Pharmaceutical Co., Ltd. news
Read company news and market updates connected to Santen Pharmaceutical Co., Ltd..
Santen Pharmaceutical Co., Ltd. investor events
Find investor webinars, events, and replay context for Santen Pharmaceutical Co., Ltd..
Alternate listings
4536:TSE
JP · JPY
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 864318:LS.
SNPHY:OTC
US · USD
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 864318:LS.
864318:LSX
DE · EUR
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 864318:LS.
SNPHF:OTC
US · USD
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 864318:LS.
SZD:GETTEX
DE · EUR
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 864318:LS.
SZD:FWB
DE · EUR
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 864318:LS.
SZD:TRADEGATE
DE · EUR
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 864318:LS.
SZD:DUS
DE · EUR
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 864318:LS.
SZD0:GETTEX
DE · EUR
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 864318:LS.
SZD:HAN
DE · EUR
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 864318:LS.
4536N:BIVA
MX · MXN
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 864318:LS.
4536N:BMV
MX · MXN
Alternate listing for Santen Pharmaceutical Co., Ltd.; the primary context on this page is 864318:LS.